Cargando…
Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era
Antibiotic resistance is one of the biggest threats to global health, as it can make the treatment of bacterial infections in humans difficult owing to their high incidence rate, mortality, and treatment costs. Bacteriophage, which constitutes a type of virus that can kill bacteria, is a promising a...
Autores principales: | Ling, Hao, Lou, Xinyu, Luo, Qiuhua, He, Zhonggui, Sun, Mengchi, Sun, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764073/ https://www.ncbi.nlm.nih.gov/pubmed/36561998 http://dx.doi.org/10.1016/j.apsb.2022.05.007 |
Ejemplares similares
-
Bacteriophages: Protagonists of a Post-Antibiotic Era
por: Domingo-Calap, Pilar, et al.
Publicado: (2018) -
Pure redox-sensitive paclitaxel–maleimide prodrug nanoparticles: Endogenous albumin-induced size switching and improved antitumor efficiency
por: Lou, Xinyu, et al.
Publicado: (2021) -
Bacteria-Mediated Synergistic Cancer Therapy: Small Microbiome Has a Big Hope
por: Lou, Xinyu, et al.
Publicado: (2021) -
The Post-Antibiotic Era: A New Dawn for Bacteriophages
por: Jin, Youshun, et al.
Publicado: (2023) -
Immunogenic Nanovesicle‐Tandem‐Augmented Chemoimmunotherapy via Efficient Cancer‐Homing Delivery and Optimized Ordinal‐Interval Regime
por: Sun, Mengchi, et al.
Publicado: (2022)